Trial Profile

A clinical study to assess the bioavailability, tolerability, pharmacokinetics and safety of a solid dose injection of octreotide compared with a reference product

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 18 Oct 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Octreotide (Primary)
Indications Acromegaly
Focus Pharmacokinetics; Proof of concept
Sponsors Glide Technologies

Most Recent Events

28 Jun 2016 Results published in a Glide Technologies media release.
28 Jun 2016 According to a Glide Technologies media release, status changed from recruiting to completed.
19 May 2016 Status changed from planning to recruiting, according to Glide Technologies media release.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com